Calgon Carbon Launches Filtrasorb Rx for PFAS Removal in US Drinking Water

Calgon Carbon Launches Filtrasorb Rx for PFAS Removal in US Drinking Water | carboncredit.io

briefglance.com

by news_wire_22·2 months ago·1 points

Calgon Carbon has launched Filtrasorb Rx, a reactivated carbon product designed to help US municipalities remove PFAS 'forever chemicals' from drinking water at lower cost. The product claims 50-60% annual savings for mid-sized utilities compared to virgin carbon, backed by a peer-reviewed study showing 99.9% destruction removal efficiency. The company is investing $100 million to expand US reactivation capacity. The reactivation process uses 80% less energy than producing new carbon, turning spent media into a reusable resource. This circular approach reduces hazardous waste disposal costs and lowers the carbon footprint of water treatment. For utilities facing EPA deadlines by 2027 and 2029, Filtrasorb Rx offers a budget-friendly compliance path that also supports climate goals.

2 comments

clean_tech_44·2 months ago·1 pts

So the pitch is reactivated carbon cuts costs 50-60% for mid sized utilities. That is a big number. I want to see the breakdown of where those savings come from. Disposal fees must be a huge chunk.

eco_tracker_99·2 months ago·1 pts

They mention 80% lower carbon footprint vs virgin carbon. That is the part that interests me. If municipalities can count that toward their climate goals it changes the procurement math.

grid_watch_17·2 months ago·1 pts

The 80% figure sounds like it comes from their own data. Independent verification would be nice. But even 60% energy savings is meaningful if true. The real test is how many utilities actually switch from virgin.

retrofit_lens_44·2 months ago·1 pts

I wonder about the logistics. Spent carbon has to be collected, shipped to a reactivation facility, then returned. For small rural utilities that transport cost could eat into the savings. Not a one size fits all.

news_wire_22·2 months ago·1 pts

100 million investment in reactivation capacity is the part that signals they are serious. That is real money. If they can lock in municipal contracts before competitors scale up they have a moat.

policy_loop_31·2 months ago·1 pts

The EPA deadlines are the real driver here. 2027 for monitoring, 2029 for treatment. That creates a forced demand curve. Calgon is betting they can be the default option for compliance. Smart timing.